Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

About: Aviva Lev-Ari, PhD, RN

Website

http://pharmaceuticalintelligence.wordpress.com

Details

Founder & Director of Leaders in Pharmaceutical Business Intelligence (LPBI) Venture Value Creator @LPBI: VENTURE #1: e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical Open Access Online Scientific Journal http://pharmaceuticalintelligence.com VENTURE #2: BioMedical e-Books e-Series: Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine http://pharmaceuticalintelligence.com/biomed-e-books/ VENTURE #3: International Scientific Delegations http://pharmaceuticalintelligence.com/scientific-delegation VENTURE #4: Funding, Deals & Partnerships http://pharmaceuticalintelligence.com/joint-ventures/ Corporate Clients for our Services Funding Cardiovascular Medical Devices Development Funding Biologics Development Funding Diagnostics Funding Partnerships in IP Development M&A and Exit Targeting Penetration in New Markets for High Technology Products Management of Engineering Design of Prototypes Outsourcing VENTURE #5: IP Invented HERE! VENTURE # 6: PRESS Coverage of Conferences http://pharmaceuticalintelligence.com/press-coverage/ - University of California, Berkeley, PhD '83 - Stanford University - GSB Exchange Program, 1980/81 - Northeastern University, Biological Sciences & Nursing '07 Worked at Director level with Start-ups and Fortune 100 companies making presentations at the CEO Board Room level. Start ups: TimeØ Group, Concept Five Technologies, Inc., MDSS, Inc.; Top Tier Management Consulting: SRI International, Monitor Group; OEM: Amdahl Corporation; Top 6th System Integrator: Perot System Corporation; FFRDC: MITRE Corporation. In the Publishing industry: McGraw-Hill/CTB. Researcher on Cardiovascular Pharmaco-therapy at Bouve College of Health Sciences, Northeastern University.

Posts by Aviva Lev-Ari, PhD, RN:

• October 4, 2025 #WMIF25 – World Medical Innovation Forum, Sept. 15-17, 2025, Boston – Clinical experts, industry, investment leaders

• September 19, 2025 Hypertention: New Guidelines for Treatment and Renal Denervation Methods approved by FDA underway to be covered by Medicare

• September 19, 2025 Good News: Life Sciences Innovations in Academic Centers in Israel in 2025

• July 24, 2025 Hypercortisolism in Difficult-to-Control Cardiometabolic Conditions: Type 2 Diabetes and Hypertension

• July 8, 2025 Dr. Zelig Eshhar, A Founding Father of CAR-T cell Immunotherapy passed away on 7/4/2025

• April 30, 2025 LPBI Group’s Legacy and Biography of Aviva Lev-Ari, PhD, RN, Founder & Director – INTERACTIVE CHAT with Grok, created by xAI

• April 29, 2025 “Show Thinking” by AI Deep Research: The AI-generated Biography Description of Aviva Lev-Ari, PhD, RN, Founder of PharmaceuticalIntelligence.com by Perplexity.ai and by Google’s Gemini 2.5 Pro (experimental)

• February 27, 2025 Advanced AI: TRAINING DATA, Sequoia Capital Podcast, 31 episodes

• January 28, 2025 DeepSeek-V3 and Reasoning Model R1: Four Views (a) Explanations (b) The Chinese Perspective (c) DeepSeek Impact on Demand for Inference Chips & Training Chips, and (d) LPBI Group: Expert Content for ML Models in Healthcare, Pharmaceutical, Medical and Life Sciences

• January 16, 2025 Paul G. Yock, Recipient of the 2024 National Medal of Technology and Innovation, Professor of Cardiovascular Medicine at Stanford Medical School

« Newer Posts - Older Posts »